Back

Myocardial damage as a result of implantation and defibrillation testing in transvenous and subcutaneous implantable cardioverter-defibrillators.

17 March 2019 (16:57 - 17:06)
Organised by:
Congress Presentation Part of: Rapid Fire 4: The shocking truth of device therapy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Anne-Floor Barbara Eleonore Quast

Academic Medical Centre, Amsterdam (Netherlands (The))

9 More presentations in this session

Presentation thumbnail
Refining ICD decision-making in non-ischaemic patients in the post-DANISH era: analysis from a nationwide database of daily remote-monitoring transmissions in a real-world cohort
Doctor G. Forleo (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Long-term performance of contemporary internal cardioverter defibrillator leads: a single center experience
Doctor R. Brenner (St. Gallen, CH)
Abstract Slides Video
Presentation thumbnail
Incidence of appropriate therapy and mortality after ICD generator replacement: results from a real-world nationwide prospective cohort
Doctor M. Ruwald (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Depression and anxiety during the first 12 months post-implant: a matched cohort study of patients with a subcutaneous implantable defibrillator and patients with a transvenous system
Professor S. Schmidt Pedersen (Odense, DK)
Abstract Slides Video
Presentation thumbnail
Predictors of acute effectiveness of subcutaneous implantable cardioverter-defibrillator according to the implantation technique
Doctor P. Francia (Rome, IT)
Abstract

Access the full session

Session thumbnail
Rapid Fire 4: The shocking truth of device therapy

The Event

Event poster

EHRA 2019

17 March 2019 16:57 CET
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources